We go by the philosophy, solving the unsolved, reaching the unreached and serving the unserved.
We believe that health and wellbeing are the main sources of happiness for humankind. Our goal is to preserve that happiness by developing and producing patient friendly medicines.
Research & Development
Our R&D capabilities are aligned to reverse-engineering high-value molecules, developing bioequivalent oncology formulations, and ensuring regulatory readiness across emerging and regulated markets.
Key focus areas:
Astra Generics adheres to stringent quality assurance protocols at every stage of manufacturing. Our facilities are designed to comply with:
WHO-GMP and cGMP guidelines.
ISO quality certifications.
Regulatory frameworks for USFDA, EMA, TGA, and WHO PQ markets.
Key Compliance Features:
Robust in-process quality checks.
Analytical development laboratories.
Documented batch traceability and risk management.
Stability studies supporting global submissions.
Astra Generics serves oncology markets across:
Asia & Middle East – India, UAE, Cambodia, Vietnam.
Africa – Nigeria, South Africa, Kenya, Mauritius.
Latin America & Caribbean – Dominican Republic, Brazil.
Eastern Europe & Russia – with a growing oncology portfolio.
Our distribution strategy is built on long-term alliances with regional partners, hospital networks, and government tenders.
